Introduction
In April 2009, the pandemic H1N1 2009 influenza virus (pH1N1) emerged in Mexico and rapidly spread to countries worldwide. 1 While previous investigations regarding seasonal (H1N1, H3N2) and H5N1 influenza have shown that the level of viral replication influences outcome, 2, 3 prospective studies illustrating the correlation between disease severity and both initial viral load and serial change of viral shedding among patients with pH1N1 influenza remain limited.
Recent studies, as well as our own observation, have demonstrated relatively low sensitivities of rapid influenza diagnostic tests (RIDT) in severe cases of pH1N1 infection. [4] [5] [6] [7] Based on the fact that viral load is a major determinant of the sensitivity of RIDT, 8, 9 we hypothesized that at the point when patients with pH1N1 infection arrive at hospital, the severity of the disease may not be well correlated with viral load in the upper respiratory tract.
We therefore conducted a prospective study to assess the profile of viral shedding among patients with complicated and uncomplicated pH1N1 infection and to determine whether there was a correlation between viral loads and disease severity.
Methods

Patients and data collection
This was a prospective observational study on patients with pH1N1 infections who presented to National Taiwan University Hospital (NTUH), a 2200-bed teaching hospital, which provided both primary and tertiary medical care including acute medical service. From July 15, 2009 to July 23, 2010, both inpatients and outpatients aged 16 years or older with influenza-like illness (ILI) were enrolled for evaluation of eligibility after the informed consent was obtained. The flu-like symptoms were defined according to the Centers for Disease Control of Taiwan with (1) any of the following: myalgia, headache, or malaise; plus (2) all of the following: (i) sudden onset of fever with a body temperature equal to or higher than 38°C by a tympanic thermometer, plus respiratory symptoms and (ii) exclusion of simply rhinorrhea, tonsillitis, and bronchitis. A standardized case report form was used to collect patient data including demographics, comorbidities, influenza vaccination status, date of fever onset, clinical presentation and outcomes, use of antiviral agents, and laboratory and radiological findings. A RIDT (QuickVue; Quidel, San Diego, CA, USA) and nasopharyngeal swab for viral quantitative real-time reverse transcriptase PCR (RT-PCR) (Applied Biosystems, Foster City, CA, USA) were collected at first hospital visit. In the case of a positive RT-PCR result, nasopharyngeal swabs for quantitative RT-PCR were sequential collected daily for the first 5 days and then every 2 days until viral genomes became undetectable for two successive specimens. The nasopharyngeal swabs were transported in 1AE2 ml of DMEM medium to our laboratory immediately after specimens were obtained and then stored at )80°C before processing. Based on recommendations by local health authorities during the study period, antiviral treatment would be considered for cases with ILI who tested positive of RIDTs or those with risk factors for complicated influenza. This study was approved by the ethical board of NTUH.
Virological analysis
Extraction of viral RNA from clinical specimens Viral RNA from 400 ll of specimen suspension was extracted with the MagMAX TM Viral RNA isolation Kit (Applied Biosystem) according to the manufacturer's instructions, and finally eluted in 50 ll ddH 2 O.
Real-time quantitative RT-PCR
Real-time RT-PCR (rRT-PCR) amplification and detection was performed in a Step One real-time PCR machine (Applied Biosystems) using the AgPath-ID one-step RT-PCR kit (Amion, Austin, TX, USA). The 25-ll reaction volume for each sample contained 5 ll of extracted RNA, 12AE5 ll of AgPath Kit 2· buffer, 1 ll of AgPath 25· enzyme mix, and 5 pmol of Taqman probe, and 10 pmol of each of the forward and reverse primers, and 6 ll of ultrapure DNase-RNase-free distilled water. All of the PCR were performed in duplicates. The cycling conditions included a reverse transcription step at 50°C for 30 minutes, and the amplification was performed for 45 cycles as follows: 94°C for 15 seconds, 55°C for 30 seconds, 55°C for 30 seconds. For all PCR testing, a cycle threshold £40 was interpreted as positive. The detection limit was 10 copies ⁄ ll.
Primer and probe
We used the Inf A (H1N1) MGB Assay (Applied Biosystems). The rRT-PCR protocol including designs of primers and probes were applied for pandemic 2009 H1N1 influenza virus detection according to CDC recommendations. 10 TaqMan dual-labeled probes were designed based on CDC probe sequences with 6-carboxyfluorescein (FAM) reporter and non-fluorescent quencher coupled with minor grove binder (MGB). The ribonuclease P (RNaseP) RT-PCR was used both as an internal control and to check for the presence of human nucleic acids and indicates the presence of a sufficient amount of cells in the sample.
Standard construction and sensitivity test
The amplified influenza M1 gene was cloned into pGEMTeasy and amplified in Escherichia coli. Plasmid-insert DNA sequences were verified by sequencing in both directions using dye-labeled dideoxy-terminator cycle sequencing. Sequences were analyzed using an ABI Model 3730. The concentration of the plasmid DNA was calculated by measuring the Qubit Fluorometer (Invitrogen, Carlsbad, CA, USA). Plasmid DNA was then serially diluted tenfold in ddH 2 O, ranging from 10 7 to 10 0 copies ⁄ ll, and used for the sensitivity test. Standard curves were produced with each assay.
Statistical analysis
All statistical analyses were performed using the Statistical Package for Social Sciences (version 17AE0; SPSS, Chicago, IL, USA). Patients with confirmed pH1N1 infections were classified into complicated group if hospitalization was required because of the development of pneumonia, neurological complications, invasive bacterial infection, myocarditis, or pericarditis. Otherwise, patients treated at outpatient clinics or emergency department for mild illness were categorized into uncomplicated group. Categorical variables were compared using chi-square or Fisher's exact test when appropriate; continuous variables were analyzed with Student's t-test. Potential predictors of development of complications among patients with pH1N1 were identified by univariate and then multivariate analysis. Variables with P value £0AE05 in the univariate analysis were further tested by means of logistic regression using the backward conditional method. Two-tailed P values of <0AE05 will be considered to be statistically significant.
Results
Patient characteristics
Between July 15, 2009 and July 23, 2010, a total of 149 patients with ILI were enrolled in our study. Of these, 64 patients (21 from the emergency department and 43 from outpatient clinics) tested positive for both influenza A virus M gene and pandemic H1N1 2009 influenza virus H1 gene by RT-PCR. The remaining patients' infections were caused by H3N2 (26) and influenza B (6), respectively. Among those with confirmed pH1N1 influenza, 18 (28%) were hospitalized owing to complications ( Table 1 ) and nine of them required ICU admission. One patient had concomitant Klebsiella pneumoniae bacteremia at presentation. Two patients required extracorporeal membrane oxygenation support. One of them, a 33-year-old male patient with no underlying medical conditions, died of multiorgan failure after having been hospitalized for 3 months.
Demographic data and clinical characteristics of uncomplicated and complicated patients are illustrated in Table 2 . A substantial proportion of patients (80%) in the uncomplicated group had no underlying medical conditions, whereas half of the patients in the complicated group had one or more comorbidities. All patients received RIDTs on presentation. The positive rates in patients with and without complications were 91% and 67%, respectively (P = 0AE02).
Despite antiviral therapy, we frequently observed prolonged duration of fever in the complicated group (mean, 5AE3 days). Classical influenza symptoms including cough, myalgia, and headache were presented more commonly in the uncomplicated group, while altered consciousness, chest pain, dyspnea, nausea, and vomiting were more frequently reported in patients experiencing complications on presentation. Patients with complications were also more likely to have a low lymphocyte count, rhabdomyolysis, and an elevated serum C-reactive protein (CRP) level.
The length of time between onset of fever and seeking medical help was significantly greater for patients in the complicated group. Although all patients received oseltamivir immediately after diagnosis, the mean time from onset of fever to initiation of oseltamivir treatment was significantly longer in the complicated group (4AE5 ± 3AE9 versus 2AE2 ± 0AE8 days, P < 0AE001).
Comparisons of viral loads and duration of viral shedding
Overall, we collected 161 nasopharyngeal swab specimens from 64 patients with laboratory-confirmed pH1N1 infection and tested them for viral load. On presentation, the mean initial viral load of the uncomplicated group was higher than the complicated group (3AE4 ± 1AE6 log 10 copies ⁄ ll versus 1AE9 ± 1AE7, P = 0AE02). We further compared the nasopharyngeal viral loads between the two groups stratified by the day after symptom onset ( Figure 1) . Although statistical insignificance, nasopharyngeal viral loads were higher in the uncomplicated group for the first 3 days. Peak viral shedding occurred within 2 days of symptom onset in both groups. A slower decline and prolongation of viral shedding were observed in the complicated group, whereas all uncomplicated patients had undetectable viral RNA by RT-PCR by day seven after onset of symptoms.
Irrespective of disease severity, viral shedding started to decrease after oseltamivir was initiated (Figure 2 ). RT-PCR results of nasopharyngeal swabs became negative within 5 days of initiation of oseltamivir in all uncomplicated patients. In the complicated group, however, viral genome could still be detected on day 5 and day 7 after initiation of antiviral treatment in 61% and 44% of the patients, respectively.
The results of univariate and multivariate analysis are shown in Table 3 . After adjustments, the only factors associated with the development of complications among patients with pH1N1 infection were age (OR, 1AE1; 95% CI, 1AE0-1AE1) and initial nasopharyngeal viral load (OR, 0AE5; 95% CI, 0AE3-0AE8). Although all patients received oseltamivir at presentation, delayed antiviral therapy were frequently observed among patients in complicated group.
Discussion
This prospective study demonstrates that initial viral load in the upper respiratory tract of patients with complicated 
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Comparisons of mean viral loads between uncomplicated and complicated groups using Student's t test.
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reported that pH1N1 virus was detected predominantly in specimens from the lower respiratory tract of a child, but was absent or at very low levels in nasopharyngeal swab samples. These observations can be attributed to a greater binding ability of pH1N1 to a2-3-linked sialyl glycans, which are predominant in the lower respiratory tract, than to a2-6-linked receptors, which are more common in the upper respiratory tract instead. 19 Hence, the upper respiratory tract may not be the optimal site for detecting or monitoring replication of the virus in severe cases of pH1N1 influenza.
While adults with seasonal influenza are generally considered infectious from the day before onset of symptoms until approximately 5 days after onset, 20 data regarding the duration and profile of viral shedding in adult patients with pH1N1 influenza, especially those with complications, are limited. Our observation that patients with complicated diseases had slower decline of viral load and prolonged viral shedding are consistent with a recent retrospective study. 13 These may be caused by failure to mount an effective innate and adaptive response, and delay of antiviral treatment. 21 As we did not test for oseltamivir resistance, we were unable to determine whether prolonged viral shedding in patients with complications was attributed to oseltamivir-resistant influenza virus. Nevertheless, national surveillance data of antiviral resistance by Taiwan Centers for Disease Control showed that only 0AE7% of pH1N1 influenza virus in Taiwan was resistant to oseltamivir during the study period. 22 At present, although the relationship between viral shedding measured by a quantitative RT-PCR and viral transmission has not been clearly demonstrated, our observations of prolonged virus detection in the upper respiratory tract, several days after antiviral treatment, may have implications for infection control. We recommend further clinical investigation into the effects of prolonged use of oseltamivir in immunocompromised or critical patients.
Consistent with previous reports, our results showed that younger adults (<65 years old) might also be hospitalized for severe pH1N1 influenza, and the risk for complications among adult patients increased with age. 13, 23, 24 However, none of the complicated cases in our cohort were morbidly obese. Other non-Western studies also suggest that morbid obesity is not a significant risk factor for severe case. [25] [26] [27] Racial differences in the prevalence of obesity should be taken into account when interpreting potential risk factors for complications among patients with pH1N1 influenza.
There were limitations to the present study. First, as a result of limited sample size, the importance of predictors might be underestimated. Second, as we did not perform sampling of lower respiratory specimens simultaneously, which usually requires invasive procedures, we were unable to demonstrate the differences of viral load between the upper and lower respiratory tracts among patients with and without complications. Nevertheless, our observation that severe cases are more likely to have lower initial viral load in upper respiratory tract justifies careful interpretation of negative RIDT or PCR results among these patients. Third, although serial specimens were obtained for analysis, different numbers of specimens were included at different intervals because the point at which the first specimen could be obtained varied in each patient, and a small number of patients refused sampling during the follow-up period. Lastly, the relatively high positive rate of RIDTs among our study population was probably attributed to sampling bias because those who tested positive were more willing to be enrolled in our study.
In conclusion, patients with complicated pH1N1 infection have prolonged viral shedding but not a higher initial viral load in the upper respiratory tract on presentation OR, odds ratio; CI, confidence interval. *Included any one of the underlying diseases specified in Table 2 .
when compared with patients with mild illness. This partially accounted for a relatively lower sensitivity of RIDTs among complicated patients. More vigilant surveillance of the lower airway and timely antiviral therapy are required for severe cases with suspected pH1N1 infection but negative RIDTs results. In addition, further research to compare the viral loads in upper and lower respiratory tracts among patients with severe pH1N1 infection is warranted.
